SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001387131-22-000438
Filing Date
2022-01-18
Accepted
2022-01-18 17:30:35
Documents
1
Group Members
DAVID BONDERMANJAMES G. COULTERJON WINKELRIED

Document Format Files

Seq Description Document Type Size
1 AMENDED SCHEDULE 13D fusion_sc13da-011822.htm SC 13D/A 126283
  Complete submission text file 0001387131-22-000438.txt   127884
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Subject) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91552 | Film No.: 22536066
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102 (817) 871-4000
TPG GP A, LLC (Filed by) CIK: 0001903793 (see all company filings)

IRS No.: 872054646 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A